NCT04388111View on ClinicalTrials.gov

Intraosseous Morphine in Primary TKA

PHASE4CompletedINTERVENTIONAL
Enrollment

65

Participants

Timeline

Start Date

May 5, 2020

Primary Completion Date

April 30, 2021

Study Completion Date

May 31, 2021

Conditions
Knee DiseaseArthritis KneePain, Acute
Interventions
DRUG

Morphine

10mg of Morphine delivered Intraosseously

Trial Locations (1)

77030

Houston Methodist Hospital, Houston

All Listed Sponsors
lead

The Methodist Hospital Research Institute

OTHER

NCT04388111 - Intraosseous Morphine in Primary TKA | Biotech Hunter | Biotech Hunter